132 related articles for article (PubMed ID: 6434869)
1. The enzyme defects in hereditary tyrosinaemia type I.
Furukawa N; Hayano T; Sato N; Inoue F; Machida Y; Kinugasa A; Imashuku S; Kusunoki T; Takamatisu T
J Inherit Metab Dis; 1984; 7 Suppl 2():137-8. PubMed ID: 6434869
[No Abstract] [Full Text] [Related]
2. Proceedings: Biochemical studies on a patient with features suggestive of hereditary tyrosinaemia.
Chalmers RA; Liberman M; Watts RW
Clin Sci Mol Med; 1974 Feb; 46(2):14P. PubMed ID: 4817255
[No Abstract] [Full Text] [Related]
3. Enzyme defect in a case of tyrosinemia type I, acute form.
Furukawa N; Kinugasa A; Seo T; Ishii T; Ota T; Machida Y; Inoue F; Imashuku S; Kusunoki T; Takamatsu T
Pediatr Res; 1984 May; 18(5):463-6. PubMed ID: 6145143
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of fumarylacetoacetase in a patient with hereditary tyrosinemia.
Berger R; Smit GP; Stoker-de Vries SA; Duran M; Ketting D; Wadman SK
Clin Chim Acta; 1981 Jul; 114(1):37-44. PubMed ID: 7249373
[TBL] [Abstract][Full Text] [Related]
5. Type I hereditary tyrosinaemia: presentation of 11 cases.
Coşkun T; Ozalp I; Koçak N; Yüce A; Caglar M; Berger R
J Inherit Metab Dis; 1991; 14(5):765-70. PubMed ID: 1664010
[TBL] [Abstract][Full Text] [Related]
6. Neonatal and prenatal diagnosis of hereditary tyrosinaemia.
King GS; MacKenzie F; Pettit BR
Lancet; 1983 Jun; 1(8336):1279. PubMed ID: 6134070
[No Abstract] [Full Text] [Related]
7. Type I tyrosinemia: lack of immunologically detectable fumarylacetoacetase enzyme protein in tissues and cell extracts.
Berger R; Van Faassen H; Taanman JW; De Vries H; Agsteribbe E
Pediatr Res; 1987 Oct; 22(4):394-8. PubMed ID: 3317254
[TBL] [Abstract][Full Text] [Related]
8. The source of aromatic ketoacids in tyrosinaemia and phenylketonuria.
Fellman JH; Buist NR; Kennaway NG; Swanson RE
Clin Chim Acta; 1972 Jun; 39(1):243-6. PubMed ID: 4402641
[No Abstract] [Full Text] [Related]
9. Tyrosinaemia type I with normal levels of plasma tyrosine.
de Almeida IT; Leandro PP; Silva MF; Silveira C; da Silva A; de Sousa JS; Duran M
J Inherit Metab Dis; 1990; 13(3):305-7. PubMed ID: 2122090
[No Abstract] [Full Text] [Related]
10. Deficient fumarylacetoacetate fumarylhydrolase activity in lymphocytes and fibroblasts from patients with hereditary tyrosinemia.
Kvittingen EA; Halvorsen S; Jellum E
Pediatr Res; 1983 Jul; 17(7):541-4. PubMed ID: 6622096
[TBL] [Abstract][Full Text] [Related]
11. Neonatal hyperphenylalaninemia: a differential diagnosis.
Menkes JH; Holtzman NA
Neuropadiatrie; 1970 Apr; 1(4):434-46. PubMed ID: 5538081
[No Abstract] [Full Text] [Related]
12. Assay of fumarylacetoacetate fumarylhydrolase in human liver-deficient activity in a case of hereditary tyrosinemia.
Kvittingen EA; Jellum E; Stokke O
Clin Chim Acta; 1981 Sep; 115(3):311-9. PubMed ID: 7296877
[TBL] [Abstract][Full Text] [Related]
13. Hepatic tyrosine aminotransferase in tyrosinaemia type II.
Kida K; Takahashi M; Fujisawa Y; Matsuda H; Machino H; Miki Y
J Inherit Metab Dis; 1982; 5(4):229-30. PubMed ID: 6133036
[No Abstract] [Full Text] [Related]
14. Microassay of tyrosine-amino transferase and p-hydroxyphenylpyruvic acid oxidase in mammalian liver and patients with hereditary tyrosinemia.
Whelan DT; Zannoni VG
Biochem Med; 1974 Jan; 9(1):19-31. PubMed ID: 4150247
[No Abstract] [Full Text] [Related]
15. Increased excretion of coproporphyrin I in a patient with hereditary tyrosinaemia type I: relevant changes with NTBC treatment.
Depetris-Boldini C; Galetto R; Videla MP; de Kremer Dodelson R
J Inherit Metab Dis; 1999 May; 22(3):227-30. PubMed ID: 10384374
[No Abstract] [Full Text] [Related]
16. Possibilities for treatment and for early prenatal diagnosis of hereditary tyrosinaemia.
Holme E; Lindblad B; Lindstedt S
Lancet; 1985 Mar; 1(8427):527. PubMed ID: 2857895
[No Abstract] [Full Text] [Related]
17. Putative genetic deficiency of 4-hydroxyphenylpyruvic acid dioxygenase in mice: a murine model for hereditary tyrosinaemia type III.
Endo F; Katoh H; Matsuda I
J Inherit Metab Dis; 1990; 13(5):780-2. PubMed ID: 2246865
[No Abstract] [Full Text] [Related]
18. Tyrosinaemia type 1 and glutathione synthetase deficiency: two disorders with reduced hepatic thiol group concentrations and a liver 4-fumarylacetoacetate hydrolase deficiency.
Lloyd AJ; Gray RG; Green A
J Inherit Metab Dis; 1995; 18(1):48-55. PubMed ID: 7623442
[TBL] [Abstract][Full Text] [Related]
19. Identification of a stop mutation in five Finnish patients suffering from hereditary tyrosinemia type I.
St-Louis M; Leclerc B; Laine J; Salo MK; Holmberg C; Tanguay RM
Hum Mol Genet; 1994 Jan; 3(1):69-72. PubMed ID: 8162054
[TBL] [Abstract][Full Text] [Related]
20. A new variant form of hypertyrosinaemia due to 4-hydroxyphenylpyruvic acid oxidase deficiency.
Endo F; Kitano A; Uehara I; Nagata N; Matsuda I; Shinka T; Kuhara T; Matsumoto I
J Inherit Metab Dis; 1982; 5(4):237-8. PubMed ID: 6133038
[No Abstract] [Full Text] [Related]
[Next] [New Search]
